中年甘油三酯升高预测20年后脑β-淀粉样蛋白和tau蛋白病理
该纵向队列研究纳入318名中年认知正常者(平均54岁),检测空腹血脂,20年后(平均73岁)通过脑脊液生物标志物和部分PET评估阿尔茨海默病病理。结果显示中年甘油三酯升高独立关联20年后脑脊液Aβ42异常和Aβ42/p-tau比值异常,提示血脂参与AD早期发展。
要点
- 中年甘油三酯升高与20年后脑脊液Aβ42异常风险增加相关(OR 1.34)。
- 甘油三酯升高还关联Aβ42/p-tau比值异常(OR 1.46),提示Aβ和tau病理。
- 某些脂蛋白亚组分可能与Aβ病理风险相关。
核心结论
- 中年甘油三酯升高预测认知正常个体20年后脑Aβ和tau病理。
- 某些脂蛋白亚组分可能是Aβ病理的危险因素。
- 脂质参与阿尔茨海默病早期发展。
研究设计与样本
- 纵向队列研究,纳入318名认知正常个体,中年(平均54岁)检测空腹血脂,20年后(平均73岁)通过脑脊液生物标志物评估AD病理,其中134人进行Aβ PET。
主要发现
- 约20%认知健康人群存在Aβ病理(脑脊液Aβ42和Aβ PET),16%存在Aβ和tau病理(脑脊液Aβ42/p-tau比值)。
- 中年甘油三酯较高独立关联脑脊液Aβ42异常(OR 1.34,95%CI 1.03-1.75,p=0.029)。
- 中年甘油三酯较高独立关联脑脊液Aβ42/p-tau比值异常(OR 1.46,95%CI 1.10-1.93,p=0.009)。
- 甘油三酯与Aβ PET异常在多变量模型中相关,但完全调整后关联减弱。
- 中和大LDL亚组分与Aβ PET异常显著相关,大HDL颗粒与Aβ PET异常风险降低相关。
临床怎么用
- 中年血脂管理可能有助于降低远期阿尔茨海默病病理风险。
- 甘油三酯可作为认知正常中年人AD早期风险分层的参考指标。
局限性
- 样本量有限,PET子集样本更小(n=134)。
- 甘油三酯与Aβ PET的关联在完全调整后减弱,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effect of midlife lipid levels on Alzheimer brain pathology 20 years later in cognitively normal elderly individuals. METHODS: This is a longitudinal cohort study of 318 cognitively normal individuals with data on fasting lipid levels at midlife (mean age 54 years). Presence of β-amyloid (Aβ) and tau pathologies 20 years later (mean age 73 years) were detected by quantifying Alzheimer disease (AD) biomarkers in CSF. In a subset (n = 134), Aβ (18F-flutemetamol) PET was also performed. RESULTS: CSF Aβ42 and Aβ PET revealed Aβ pathology in approximately 20% of the cognitively healthy population and CSF Aβ42/phosphorylated tau (p-tau) ratio indicated both Aβ and tau pathology in 16%. Higher levels of triglycerides in midlife were independently associated with abnormal CSF Aβ42 (odds ratio [OR] 1.34, 95% confidence interval [CI] 1.03-1.75, p = 0.029) and abnormal Aβ42/p-tau ratio (OR 1.46, 95% CI 1.10-1.93; p = 0.009) adjusting for age, sex, APOE ε4, education, and multiple vascular risk factors. Triglycerides were also associated with abnormal Aβ PET in multivariable regression models, but the association was attenuated in the fully adjusted model. Increased levels of medium and large low-density lipoprotein subfractions were significantly associated with abnormal Aβ PET and large high-density lipoprotein particles were associated with decreased risk of abnormal Aβ PET. CONCLUSIONS: Increased levels of triglycerides at midlife predict brain Aβ and tau pathology 20 years later in cognitively healthy individuals. Certain lipoprotein subfractions may also be risk factors for Aβ pathology. These findings further support an involvement of lipids in the very early stages of AD development.
引用
- Nägga K, Gustavsson AM, Stomrud E, et al. Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later. Neurology. 2017. PMID: 29196581. doi:10.1212/WNL.0000000000004749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。